Cited by — A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults.
No admitted local citation edges point to this work yet.
